International Agency for Research on Cancer (External organisation)

McFerran, E. (Advisor)
Isabelle Soerjomataram (Contributor)

School of Medicine, Dentistry and Biomedical Sciences

Activity: Membership types › Membership of national or international committees and working groups

Description

Working within the COVID-19 and Cancer Global Modelling Consortium (CCGMC), member of the systematic review team providing evidence to inform an update of the impact of COVID-19 on cancer for the World Health Organisation (WHO).

Project lead at IARC Isabelle Soerjomataram

Period	10 Nov 2021 → …
Held at	International Agency for Research on Cancer, France
Degree of Recognition	International

Keywords

Cancer
COVID-19
Systematic Review
WHO

Documents & Links

The COVID-19 and Cancer Global Modelling Consortium (CCGMC) brings together the global modelling community to support decision-making in cancer control both during and after the crisis. Our aim is to help to configure modelling platforms and teams that can provide more informed advice to our governments, particularly those in low- and middle-income countries, as they rise to this overwhelming health systems challenge. Our focus on the longer-term, as well as the shorter-term, recognises that recovery strategies will be required as countries move beyond the acute phase of the crisis. The CCGMC is one of the three streams of work being conducted under the auspices of the COVID-19 and Cancer Taskforce, which has been established by cancer leaders in many countries. The other two streams of work aim to: Coordinate efforts to synthesise and rapidly disseminate data to inform clinical judgements and support patient decision-making while facing lockdowns and potential irregular access to treatment and care providers; and Understand the impact on health workers and provide support while addressing cross-cutting issues such as: economic impact assessment, effects on cancer inequalities and cancer research as well as identifying new practices.